3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
23
Myelodysplastic Syndromes
6
Leukemia, Myelomonocytic, Chronic
3
Neoplasms
2
Myeloproliferative Disorders
2
Hodgkin Disease
2
GATA2 Deficiency
2
Anemia, Refractory, with Excess of Blasts
2
Pathologic Complete Response
1
Neoplasm Metastasis
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Leukemia
1
Immunoblastic Lymphadenopathy
1
Hematologic Neoplasms
1
Enteropathy-Associated T-Cell Lymphoma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Rituximab
12
Cyclophosphamide
12
Biopsy
12
Specimen Handling
11
Magnetic Resonance Spectroscopy
10
obinutuzumab
7
fludarabine
7
Lenalidomide
7
Prednisone
6
pembrolizumab
5
Nuclear Medicine Department, Hospital
5
fludarabine phosphate
4
X-Rays
4
Tacrolimus
4
Mycophenolic Acid
4
Doxorubicin
4
Busulfan
4
venetoclax
3
ibrutinib
3
glofitamab
3
acalabrutinib
3
Whole-Body Irradiation
3
Vincristine
3
GSK2636771
3
Etoposide
3
Bendamustine Hydrochloride
3
zanubrutinib
2
trametinib
2
tocilizumab
2
palbociclib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma
×
Azacitidine
×
30 days
×
Clear all
No trials found.